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Abstract. Viscum album L. is a parasitic plant, widely used in addition to the treatment of
cancer. Mistletoe alcoholic extract and glycerine macerate were inoculated in 40 white Swiss male
mice, previously inoculated with Ehrlich Ascitic Carcinoma (EAC). Animals were divided in four
equal groups; first group received i.p. in the day 1, 4 and 7 - 50 mg d.s./kg b.w. Viscum album 1:1
alcoholic extract. The second group received i.p. in the day 1, 4 and 7 – 20 ml/kg b.w. Viscum album 1
to 100 glycerine extract. The third group received i.p. Doxorubicin chloride 2.5 mg/ kg b.w. in day 6
of experiment, while the last group received a placebo. Other 40 animals were injected with the same
plant extracts, placebo and Doxorubicin chloride, without EAC. In EAC group only 8 from 10 animals
survived in the end of the study, in the other groups all animals survived to the end. V. album alcoholic
extract increased the white blood cells (WBC) as compared to control, due to granulocytes (GRA), but
the most important both mistletoe extracts provided increase WBC as compared to Doxorubicin
injected group. Mistletoe extracts elevated the platelets total count (PLT) in non EAC inoculated
groups. The Viscum album alcoholic extract prevented the development of ascitic fluid, but it was less
effective in reduction of EAC cell concentration. In conclusion, Viscum album alcoholic tincture, and
glycerine macerate provided an anticancer effect; they stimulate the immune mechanisms and inhibit
the tumor cells proliferation.
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INTRODUCTION
Viscum album L. is a parasitic plant that grows on various trees. It is commonly
known as European mistletoe. Viscum album preparations are used as a complementary
medicine in cancer therapy. Although the beneficial properties of European mistletoe, Viscum
album L., has been documented throughout history, its therapeutic application has been
changing with the development of science (Ostermann et al., 2009). In our days, Viscum
album extracts are widely used in addition to the treatment of cancer (Ostermann et al., 2009).
Recently, many in vitro and in vivo studies have examined the antitumoral properties of
Viscum album extracts or certain constituents isolated from these extracts (Cebovic et al.,
2008, Khil et al., 2007), and various clinical studies revealed that mistletoe extract
preparations can improve the quality of life, and survival time span in different cancer
patients (Ostermann et al., 2009). It is thought that the molecular basis of the antitumoral
activity of mistletoe lies in two distinct bioactivities. First, its lectin content is responsible for
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direct toxicity to tumor cells (Khil et al., 2007). Secondly, the Viscum album
rhamnogalacturonan oligosaccharide favors bridging of natural killer tumor cell conjugates,
enhancing the citotoxic efficiency. Moreover, it has been found that the antitumoral human
citotoxic T lymphocytes with CD T cell receptor are selectively activated by mistletoe ligands
of phosphoantigen structure (Tabiasco et al., 2002).
MATERIALS AND METHODS
Plant materials: The Viscum album (plant raised from the apple tree – Malus
communis) was harvested from Cluj area, in November – December 2009. The vegetal
products were dried and grounded to a fine powder.
Preparation of tinctures: The Viscum album mother tincture (MT) was prepared
according to German Homoeopathic and European Pharmacopoeias, method 2a, by cold
extraction (maceration). 100 g of fresh Viscum album plant was cut to a pasta consistency
(moisture 70 %). To cut plant material was adding 70 g 90 % vol. ethanol. The plant-ethanol
mixture was macerate 10 days with periodical mixing and than pressed and filtered. The
extraction ratio was 1:1 plant to extract (mother tincture). The obtained mother tincture has
8,5 % dry residue.
The Viscum album young shoots extract – glycerine macerate (GM) was prepared
according to French Pharmacopoeia using fresh plant material. The extraction was made by
maceration using as extraction solvent a mixture of 96 % vol. ethanol and glycerol. The dry
plant extraction solvent ratio was 1 to 20. The fresh plant material was cut to pasta
consistency and that was adding the extraction solvent. The plant-extraction solvent mixture
was macerate 20 days with periodical mixing and than pressed and filtered. The obtained
extract was diluted 1 to 100 with a mixture of ethanol, glycerol and water, having an ethanol
content of 18 % vol.
To prevent toxic effect of the alcohol, often more toxic than plant compounds
dissolved in it, alcoholic solution was maintained in a water bath until 3/4 of the content
evaporates, than filed with sterile saline solution up to 0.5 ml / animal. The aqueous solution
was administrated i.p., immediately, in order to prevent the bacterial and fungus
contamination.
The animals were caged in groups of 10 per cage, at controlled temperature of 21-
22ºC, humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard
lab chow, provided by National Institute for Research and Development “Cantacuzino”
Bucharest (Batch no. 2 / 26.03.2010), and water were freely available. The animal tests and
experiments were allowed by the Bioethical Board of the Faculty of Veterinary Medicine
Cluj-Napoca.
The experiment was carried out on 40 white Swiss male mice, 35.83 ± 5.61 g body
weight; each animal received 106 ascitic cells intra peritoneal, in the day 0. The experiment
last for 14 days, in the Department of Pathophysiology, University of Agricultural Science
and Veterinary Medicine Cluj-Napoca. Ehrlich ascitic carcinoma (EAC) was a generous gift
from the Oncology Institute “I. Chiricuta” Cluj Napoca. Body weight was measured at the
beginning, and at the end of experiment.
Animals were divided in four equal experimental groups; first group mother tincture
extract (MT) received i.p. in the day 1, 4 and 7 - 50 mg d.s./kg b.w. Viscum album 1:1 plant to
extract in ethylic alcohol 70°. The second group young shoots extract (GM) was injected
intraperitoneal in the day 1, 4 and 7 – 20 ml/kg b.w. Viscum album 1 to 100 with a mixture of
ethanol, glycerol and water (ethanol 18 % vol.). The control group received 0.5 ml alcohol
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70°, i.p (after evaporation in water bath in the same way like the plant extracts) and the last
group received i.p. Doxorubicin chloride 2.5 mg/ kg b.w. (Adriablastina 10 mg – Pfizer) in
day 6 of experiment.
To assess the biological effects of substances in study, other 40 animals were subject
of administration of plant extracts, control and Doxorubicin chloride alone in the same doses,
at the same time.
In the end, the blood was harvested from the retro orbitary sinus under diethyl ether
anesthesia and the euthanasia was made by prolonged ether narcosis. Total amount of ascitic
fluid was measured, and viable tumor cell concentration was counted in a Burker camera
(liquid diluted 1:100). Cell viability was assessed by tripan blue staining (Olinescu, 1992).
Blood haematology was investigated with Abacus Junior Vet, automatic analyzer
Diatron Messtechnik, Budapest, Hungary. Blood chemistry (urea and creatinine) was
measured using screen point semiautomatic analyzer, STAT – FAX 1904 Plus, Global
Medical Instrumentation, Inc. 6511 Bunker Lake Blvd. Ramsey Minnesota, 55303 USA, by
using special determination kits in the Department of Pathophysiology, University of
Agricultural Science and Veterinary Medicine Cluj-Napoca.
Statistics - the data were expressed as the mean and standard deviation. T Student
multiple range test from Excel Windows Software was used to assess the differences among
groups. Differences at p<0.05 and p<0.01 were considered significant and respectively
distinct significant.
RESULTS AND DISCUSSION
No important changes in red blood cells has been found among experimental groups,
the total red blood cells count, hemoglobin, hematocrit and red cells indices were within
normal limit. However, increased hemoglobin and hematocrit level were found in mistletoe
treated groups (Tab. 1); due to hypercromy in red blood cells (suggested by increased medium
cellular hemoglobin MCH, and medium cellular hemoglobin concentration MCHC) but the
significance remains obscure (Tab. 2).
Tab. 1.
The hematological profile (mean ± S.D.)
RBC 1012/l HGB g/dl HCT %
EAC 6.48±1.21 9.46±1.95 28.73±5.63
EAC + Doxorubicin 7.04±0.90 11.75±1.60 35.99±4.67
EAC + MT 6.23±0.93 10.24±1.84 30.23±5.06
EAC + GM 6.57±0.20 10.59±0.76 30.83±1.78
GM 7.60±0.58 12.96±0.93* 38.08±2.40*
MT 8.28±0.22 13.50±0.40* 39.81±0.42
Doxorubicin 7.33±0.98 11.26±1.29 34.35±5.26
Control 6.67±1.40 10.26±2.22 31.74±6.05
*= statistically significant at p<0.05 as compared to Control group
Normal values: RBC 7-12.5 1012/l HGB 10.2-18 g/dl HCT 36-49 % (Uray, 1992)
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Tab. 2.
The Red Cell Indices (mean ± S.D.)
MCV fl MCH pg MCHC g/dl RDWs fl
EAC 44.20±3.35 14.56±0.83 33.00±1.61 42.06±5.26
EAC + Doxorubicin 51.00±1.82 16.72±0.48 32.70±0.36 37.30±1.92
EAC + MT 48.14±1.21 16.40±0.75 38.89±1.12 33.02±0.76
EAC + GM 46.86±3.18 16.14±1.32 34.36±0.94 37.26±3.71
GM 50.00±1.22 17.02±0.30*** 33.96±0.40** 34.20±4.04
MT 48.33±1.53 16.33±0.90* 33.90±0.96 34.13±1.22
Doxorubicin 46.80±3.08 15.31±1.32 32.66±1.13 39.06±3.60*
Control 47.78±2.11 15.34±0.59 32.13±1.025 34.03±4.03
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
***= highly statistically significant at p<0.001 as compared to Control group
Normal values: MCV 53.6-56 fl, MCH 48.1-50 pg, MCHC 31.3-33.2 g/dl (Uray, 1992)
Doxorubicin, as expected, induce a significant leucopenia as compared to control
group, and interestingly was responsible for reducing the total white blood cell count (WBC)
in EAC injected groups (EAC inoculation was related to elevated WBC concentration). The
lymphocytes were the most affected category in non EAC inoculated animals, while in EAC
inoculated ones the leucopenia was induced by decreasing of the granulocyte level.
V. album alcoholic extract (MT) provides the increase in WBC as compared to control
due to granulocytes (GRA) suggesting a neutrophilia, but the most important both mistletoe
extracts provided increase WBC as compared to Doxorubicin group. The difference was also
made by granulocytes (Tab. 3). Some peritoneal local reaction do to i.p. injection of plant
extracts was excluded by gross evaluation and cytology of peritoneal fluid made at 1, 2, 6,
and 24 hours after injection, in preliminary studies (data no shown).
Tab. 3.
The leukogram (mean ± S.D.)
WBC 109/l LYM 109/l MID 109/l GRA 109/l
EAC 62.32±45.82 9.15±6.61 2.58±3.58 50.56±44.44
EAC + Doxorubicin 15.01±9.46 8.93±3.014 0.34±0.39 5.64±6.37
EAC + MT 36.81±20.45 7.84±1.99 2.50±3.38 26.47±15.80
EAC + GM 32.88±6.84 8.70±2.77 1.63±0.41 22.56±4.91
GM 5.58±2.85 5.20±2.70 0.19±0.26 0.20±0.17
MT 7.37±1.35 6.06±0.94 0.14±0.05 1.17±0.72*
Doxorubicin 2.48±1.42** 1.74±0.94*** 0.11±0.10 0.64±0.49
Control 4.87±1.83 4.29±1.69 0.11±0.07 0.45±0.26
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
***= highly statistically significant at p<0.001 as compared to Control group
Normal values WBC 6-15 109/l (Uray, 1992)
Mistletoe extracts, induced elevated platelets total count (PLT) in non EAC inoculated
groups, but other platelets characteristics remain unchanged (Tab. 4). The alcoholic extract
(MT), seems to be more active than glycerin extract (GM). Trombocitosis was mainly related
to unspecific cellular immunity; therefore, it suggested once again an immune stimulation.
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Tab. 4.
The platelets (mean ± S.D.)
PLT 109/l PCT % MPV fl PDWs fl
EAC 648.80±205.39 0.40±0.21 6.20±0.38 6.70±0.60
EAC + Doxorubicin 498.50±110.03 0.32±0.08 6.38±0.31 6.40±0.24
EAC + MT 649.14±248.18 0.44±0.18 6.69±0.30 7.09±0.41
EAC + GM 749.57±126.34 0.47±0.09 6.29±0.23 6.60±0.56
GM 723.60±61.39** 0.45±0.08** 6.20±0.56 6.06±0.61
MT 662.33±133.72* 0.41±0.09* 6.17±0.15 6.13±0.60
Doxorubicin 643.70±190.93 0.38±0.11* 5.91±0.17 5.88±0.42
Control 389.33±181.25 0.23±0.11 5.97±0.19 5.84±0.43
*= statistically significant at p<0.05 as compared to Control group
**= statistically distinct significant at p<0.01 as compared to Control group
Normal values PLT 160-410 109/l (Uray, 1992)
In EAC group only 8 from 10 animals survived in the end of the study, in the other
three experimental groups all animals survived to the end; development of EAC was
expectedly followed by a significant increasing in body weight. Doxorubicin revealed a
strong protective effect; in treated animals, the body weight was slightly decreased. The
Viscum album mother tincture (MT) alcoholic extract provides also a strong protective effect
comparable to doxorubicin. The Viscum album young shoots extract – glycerine macerate
(GM) failed to strop the ascitic development (Fig. 1). However, the other parameters, total
amount of ascitic fluid and cellular ascitic concentration were not influenced by the mistletoe
extracts in statically significant manner (Fig. 2, 3), even lover values were found in both
experimental groups. This findings should be elucidated in further studies. No notable
changes were found in plasma biochemistry, gross evaluation and histopathology (data no
shown).
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Fig. 1. The variation on body weight among experimental groups (mean ± S.D.) (g)
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Fig. 2. The ascitic volume (mean ± S.D.) (ml)
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Fig. 3. The cellular concentration within ascitic fluid (mean ± S.D.) (106/ml)
*= statistically significant at p<0.05 as compared to Control group
In the present study, even the number of cells was lower in treated groups; the most of
them were viable (99%). Other studies found that the administration of Viscum album extract
against EAC was followed by a reduction in cell number and viability (Cebovic et al., 2008).
In some cases, especially when the mice were pretreated with the Viscum album extract, a
total absence of EAC cells was observed. Post treatment also led to a reduction in the cell
number and viability although to a lesser extent than pretreatment. These findings are in
accordance with a lower degree of oxidative stress in these EAC cells. The citotoxic
mechanism of action of the Viscum album extract on EAC development may be due to the
induction of oxidative stress in the EAC cells without simultaneously affecting the antioxidant
status of other tissues (Cebovic et al., 2008).
However, the molecular apoptotic mechanisms in tumor cells by Viscum album extract
have not been clearly elucidated. Khil et al., (2007) found that Viscum album agglutinin
induced apoptosis of colon cancer cells is due to the activation of caspases and inhibition of
anti-apoptotic proteins partly through the TNFR1 signalling pathway. Even at low dose
purified mistletoe lectins reduced also melanoma growth and number of metastases in a
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xenograft model. The enhancement of infiltration and apoptosis induction in the melanoma
cells seem to play the key role for these observed effects (Thies et al., 2008).
Cytolysis activity against tumors involves many types of effectors cells; these include
not only T-lymphocytes, but also granulocytes, activated macrophages, NK cells, and
lymphokine-activated killer cells. Mistletoe lectins (and other compounds) are able to
improve the immune reaction throughout various mechanisms, including activation of
macrophages and NK cells, but also by increasing leukocytes synthesis (Tabiasco et al.,
2002). They proved to be effective in cancer patients, subject of chemotherapy, but even more
effective in healthy subjects (Ostermann et al., 2009).
CONCLUSIONS
The Viscum album alcoholic tincture, and glycerine macerate proved a trustworthy
anticancer effect, by upholding the immune mechanisms, and, also, throughout inhibition of
tumor cells proliferation. Outstandingly they seem to increase the survival rate, and health
condition in animal models. This might be the fist step for the development of new original
anticancer remedies.
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